Head-to-Head

GeoVax Labs, Inc. New vs. Eli Lilly & Co.

GOVX

GeoVax Labs, Inc. New

$0.72 +0.03%

VS LLY

Eli Lilly & Co.

$1180.16 -2.39%

Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

GOVXLLY
Market Cap $3.74 million $1.05 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) — $26.71 billion

LLY leads on 1 of 1 size & scale factors.

Valuation

GOVXLLY
P/E Ratio — 39.62
Price / Book — 31.05
Price / Sales — 13.20

GOVX and LLY split the valuation factors evenly.

Profitability

GOVXLLY
Net Margin — 33.53%
Return on Equity — 78.84%

GOVX and LLY split the profitability factors evenly.

Dividend

GOVXLLY
Dividend Yield — 0.59%
Payout Ratio — 23.23

GOVX and LLY split the dividend factors evenly.

Risk & Sentiment

GOVXLLY
Short Interest 2.73% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: GOVX overview, GOVX financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.